Preclinical analysis of acquired resistance after prolonged efficacious metronomic oral topotecan chemotherapy plus pazopanib therapy in advanced ovarian carcinoma

ChEBI2014-02-04 更新2026-07-21 收录

卵巢癌耐药性

药物疗效评估

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-54621 数据链接链接失效反馈

官方服务：

资源简介：

Preclinical analysis of acquired resistance after prolonged efficacious metronomic oral topotecan chemotherapy plus pazopanib therapy in advanced ovarian carcinoma

创建时间：

2014-02-04

Preclinical analysis of acquired resistance after prolonged efficacious metronomic oral topotecan chemotherapy plus pazopanib therapy in advanced ovarian carcinoma

资源简介：

相关数据集